Last 12 months
Inside the activity.
3 purchase rows · 2 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 3 | 1 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 25, 2010 Filed Mar 2, 2010 02:01 UTC |
MCLEOD MARY SSenior Vice President
|
GrantCommon Stock | 32,591 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-10-006392 · doc4.xml · nonDerivative · entry 1 MCLEOD MARY S · CIK 0001209774 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 144,034 F1 · shares: The reported transaction constitutes the grant of restricted stock units, which are subject to certain vesting requirements. Read SEC document |
| February 25, 2010 Filed Mar 2, 2010 02:01 UTC |
KINDLER JEFFREY BDirector · Chairman & CEO
|
GrantStock Appreciation Rights · Derivative | 675,676 | $0.00 Strike: $17.69 | $0.00 |
DisclosureSEC source: 0001225208-10-006393 · doc4.xml · derivative · entry 5 KINDLER JEFFREY B · CIK 0001174454 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 675,676 Underlying: Common Stock · 675,676 shares Expires 2015-02-25 F3 · derivative.exercise_date: The stock appreciation rights, which are subject to certain vesting requirements will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant. F3 · derivative.expiration_date: The stock appreciation rights, which are subject to certain vesting requirements will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant. Read SEC document |
| February 25, 2010 Filed Mar 2, 2010 02:01 UTC |
KINDLER JEFFREY BDirector · Chairman & CEO
|
GrantCommon Stock | 243,482 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-10-006393 · doc4.xml · nonDerivative · entry 1 KINDLER JEFFREY B · CIK 0001174454 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 820,888 F1 · shares: The reported transaction constitutes the grant of restricted stock units, which are subject to certain vesting requirements. Read SEC document |
| February 25, 2010 Filed Mar 2, 2010 02:01 UTC |
READ IAN CSenior Vice President
|
GrantStock Appreciation Rights · Derivative | 197,072 | $0.00 Strike: $17.69 | $0.00 |
DisclosureSEC source: 0001225208-10-006394 · doc4.xml · derivative · entry 5 READ IAN C · CIK 0001372915 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 197,072 Underlying: Common Stock · 197,072 shares Expires 2015-02-25 F4 · derivative.exercise_date: The stock appreciation rights, which are subject to certain vesting requirements will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant. F4 · derivative.expiration_date: The stock appreciation rights, which are subject to certain vesting requirements will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant. Read SEC document |
| February 25, 2010 Filed Mar 2, 2010 02:01 UTC |
READ IAN CSenior Vice President
|
Tax withholdingCommon Stock | 1,617 | $17.69 | $28,604.73 |
DisclosureSEC source: 0001225208-10-006394 · doc4.xml · nonDerivative · entry 3 READ IAN C · CIK 0001372915 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 565,218 F3 · shares: The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the earn-out of Performance-Contingent Shares. Read SEC document |
| February 25, 2010 Filed Mar 2, 2010 02:01 UTC |
READ IAN CSenior Vice President
|
GrantCommon Stock | 4,581 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-10-006394 · doc4.xml · nonDerivative · entry 2 READ IAN C · CIK 0001372915 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 566,835 F2 · shares: The reported transaction constitutes the earn-out of Performance-Contingent Shares. Read SEC document |
| February 25, 2010 Filed Mar 2, 2010 02:01 UTC |
READ IAN CSenior Vice President
|
GrantCommon Stock | 84,959 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-10-006394 · doc4.xml · nonDerivative · entry 1 READ IAN C · CIK 0001372915 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 562,254 F1 · shares: The reported transaction constitutes the grant of restricted stock units, which are subject to certain vesting requirements. Read SEC document |
| February 25, 2010 Filed Mar 2, 2010 02:01 UTC |
SUSMAN SALLYSenior Vice President
|
GrantStock Appreciation Rights · Derivative | 95,721 | $0.00 Strike: $17.69 | $0.00 |
DisclosureSEC source: 0001225208-10-006395 · doc4.xml · derivative · entry 4 SUSMAN SALLY · CIK 0001263544 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,721 Underlying: Common Stock · 95,721 shares Expires 2015-02-25 F3 · derivative.exercise_date: The stock appreciation rights, which are subject to certain vesting requirements will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant. F3 · derivative.expiration_date: The stock appreciation rights, which are subject to certain vesting requirements will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant. Read SEC document |
| February 25, 2010 Filed Mar 2, 2010 02:01 UTC |
SUSMAN SALLYSenior Vice President
|
GrantCommon Stock | 39,499 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-10-006395 · doc4.xml · nonDerivative · entry 1 SUSMAN SALLY · CIK 0001263544 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 188,006 F1 · shares: The reported transaction constitutes the grant of restricted stock units, which are subject to certain vesting requirements. Read SEC document |
| February 25, 2010 Filed Mar 2, 2010 02:01 UTC |
CANGIALOSI LORETTA VSr. Vice President, Controller
|
GrantStock Appreciation Rights · Derivative | 32,939 | $0.00 Strike: $17.69 | $0.00 |
DisclosureSEC source: 0001225208-10-006396 · doc4.xml · derivative · entry 5 CANGIALOSI LORETTA V · CIK 0001174449 · Sr. Vice President, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,939 Underlying: Common Stock · 32,939 shares Expires 2015-02-25 F4 · derivative.exercise_date: The stock appreciation rights, which are subject to certain vesting requirements will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant. F4 · derivative.expiration_date: The stock appreciation rights, which are subject to certain vesting requirements will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant. Read SEC document |
| February 25, 2010 Filed Mar 2, 2010 02:01 UTC |
CANGIALOSI LORETTA VSr. Vice President, Controller
|
Tax withholdingCommon Stock | 1,069 | $17.69 | $18,910.61 |
DisclosureSEC source: 0001225208-10-006396 · doc4.xml · nonDerivative · entry 3 CANGIALOSI LORETTA V · CIK 0001174449 · Sr. Vice President, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 188,890 F3 · shares: The reported transaction constitutes withholding of shares to satisfy tax obligations upon the earn-out of Performance-Contingent Shares. Read SEC document |
| February 25, 2010 Filed Mar 2, 2010 02:01 UTC |
CANGIALOSI LORETTA VSr. Vice President, Controller
|
GrantCommon Stock | 2,951 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-10-006396 · doc4.xml · nonDerivative · entry 2 CANGIALOSI LORETTA V · CIK 0001174449 · Sr. Vice President, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 189,959 F2 · shares: The reported transaction constitutes the earn-out of Performance-Contingent Shares. Read SEC document |
| February 25, 2010 Filed Mar 2, 2010 02:01 UTC |
CANGIALOSI LORETTA VSr. Vice President, Controller
|
GrantCommon Stock | 8,148 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-10-006396 · doc4.xml · nonDerivative · entry 1 CANGIALOSI LORETTA V · CIK 0001174449 · Sr. Vice President, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 187,008 F1 · shares: The reported transaction constitutes the grant of restricted stock units, which are subject to certain vesting requirements. Read SEC document |
| February 25, 2010 Filed Mar 2, 2010 02:01 UTC |
DAMELIO FRANK ASenior Vice President
|
GrantStock Appreciation Rights · Derivative | 197,072 | $0.00 Strike: $17.69 | $0.00 |
DisclosureSEC source: 0001225208-10-006397 · doc4.xml · derivative · entry 3 DAMELIO FRANK A · CIK 0001194004 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 197,072 Underlying: Common Stock · 197,072 shares Expires 2015-02-25 F2 · derivative.exercise_date: The stock appreciation rights, which are subject to certain vesting requirements will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant. F2 · derivative.expiration_date: The stock appreciation rights, which are subject to certain vesting requirements will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant. Read SEC document |
| February 25, 2010 Filed Mar 2, 2010 02:01 UTC |
DAMELIO FRANK ASenior Vice President
|
GrantCommon Stock | 84,959 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-10-006397 · doc4.xml · nonDerivative · entry 1 DAMELIO FRANK A · CIK 0001194004 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 454,891 F1 · shares: The reported transaction constitutes the grant of restricted stock units, which are subject to certain vesting requirements. Read SEC document |
| February 25, 2010 Filed Mar 2, 2010 02:01 UTC |
Dolsten MikaelSenior Vice President
|
GrantStock Appreciation Rights · Derivative | 146,396 | $0.00 Strike: $17.69 | $0.00 |
DisclosureSEC source: 0001225208-10-006398 · doc4.xml · derivative · entry 2 Dolsten Mikael · CIK 0001437590 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 146,396 Underlying: Common Stock · 146,396 shares Expires 2015-02-25 F2 · derivative.exercise_date: The stock appreciation rights, which are subject to certain vesting requirements will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant. F2 · derivative.expiration_date: The stock appreciation rights, which are subject to certain vesting requirements will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant. Read SEC document |
| February 25, 2010 Filed Mar 2, 2010 02:01 UTC |
Dolsten MikaelSenior Vice President
|
GrantCommon Stock | 36,212 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-10-006398 · doc4.xml · nonDerivative · entry 1 Dolsten Mikael · CIK 0001437590 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 137,987 F1 · shares: The reported transaction constitutes the grant of restricted stock units, which are subject to certain vesting requirements. Read SEC document |
| February 25, 2010 Filed Mar 2, 2010 02:01 UTC |
MACKAY MARTINSenior Vice President
|
GrantStock Appreciation Rights · Derivative | 163,288 | $0.00 Strike: $17.69 | $0.00 |
DisclosureSEC source: 0001225208-10-006399 · doc4.xml · derivative · entry 5 MACKAY MARTIN · CIK 0001414815 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 163,288 Underlying: Common Stock · 163,288 shares Expires 2015-02-25 F4 · derivative.exercise_date: The stock appreciation rights, which are subject to certain vesting requirements will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant. F4 · derivative.expiration_date: The stock appreciation rights, which are subject to certain vesting requirements will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant. Read SEC document |
| February 25, 2010 Filed Mar 2, 2010 02:01 UTC |
MACKAY MARTINSenior Vice President
|
Tax withholdingCommon Stock | 1,127 | $17.69 | $19,936.63 |
DisclosureSEC source: 0001225208-10-006399 · doc4.xml · nonDerivative · entry 3 MACKAY MARTIN · CIK 0001414815 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 375,044 F3 · shares: The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the earn-out of Performance-Contingent Shares. Read SEC document |
| February 25, 2010 Filed Mar 2, 2010 02:01 UTC |
MACKAY MARTINSenior Vice President
|
GrantCommon Stock | 3,471 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-10-006399 · doc4.xml · nonDerivative · entry 2 MACKAY MARTIN · CIK 0001414815 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 376,171 F2 · shares: The reported transaction constitutes the earn-out of Performance-Contingent Shares. Read SEC document |
| February 25, 2010 Filed Mar 2, 2010 02:01 UTC |
MACKAY MARTINSenior Vice President
|
GrantCommon Stock | 66,017 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-10-006399 · doc4.xml · nonDerivative · entry 1 MACKAY MARTIN · CIK 0001414815 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 372,700 F1 · shares: The reported transaction constitutes the grant of restricted stock units, which are subject to certain vesting requirements. Read SEC document |
| February 25, 2010 Filed Mar 2, 2010 02:01 UTC |
Lewis-Hall Freda CSenior Vice President
|
GrantStock Appreciation Rights · Derivative | 101,351 | $0.00 Strike: $17.69 | $0.00 |
DisclosureSEC source: 0001225208-10-006400 · doc4.xml · derivative · entry 3 Lewis-Hall Freda C · CIK 0001437909 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 101,351 Underlying: Common Stock · 101,351 shares Expires 2015-02-25 F2 · derivative.exercise_date: The stock appreciation rights, which are subject to certain vesting requirements will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant. F2 · derivative.expiration_date: The stock appreciation rights, which are subject to certain vesting requirements will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant. Read SEC document |
| February 25, 2010 Filed Mar 2, 2010 02:01 UTC |
Lewis-Hall Freda CSenior Vice President
|
GrantCommon Stock | 25,070 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-10-006400 · doc4.xml · nonDerivative · entry 1 Lewis-Hall Freda C · CIK 0001437909 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,862 F1 · shares: The reported transaction constitutes the grant of restricted stock units, which are subject to certain vesting requirements. Read SEC document |
| February 25, 2010 Filed Mar 2, 2010 02:01 UTC |
Redmond Cavan M.Senior Vice President
|
GrantStock Appreciation Rights · Derivative | 90,090 | $0.00 Strike: $17.69 | $0.00 |
DisclosureSEC source: 0001225208-10-006401 · doc4.xml · derivative · entry 3 Redmond Cavan M. · CIK 0001420120 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,090 Underlying: Common Stock · 90,090 shares Expires 2015-02-25 F2 · derivative.exercise_date: The stock appreciation rights, which are subject to certain vesting requirements will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant. F2 · derivative.expiration_date: The stock appreciation rights, which are subject to certain vesting requirements will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant. Read SEC document |
| February 25, 2010 Filed Mar 2, 2010 02:01 UTC |
Redmond Cavan M.Senior Vice President
|
GrantCommon Stock | 22,284 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-10-006401 · doc4.xml · nonDerivative · entry 1 Redmond Cavan M. · CIK 0001420120 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,350 F1 · shares: The reported transaction constitutes the grant of restricted stock units, which are subject to certain vesting requirements. Read SEC document |
| February 25, 2010 Filed Mar 2, 2010 02:02 UTC |
RICCIARDI NATALE SSenior Vice President
|
GrantStock Appreciation Rights · Derivative | 73,198 | $0.00 Strike: $17.69 | $0.00 |
DisclosureSEC source: 0001225208-10-006402 · doc4.xml · derivative · entry 6 RICCIARDI NATALE S · CIK 0001107158 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,198 Underlying: Common Stock · 73,198 shares Expires 2015-02-25 F5 · derivative.exercise_date: The stock appreciation rights, which are subject to certain vesting requirements will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant. F5 · derivative.expiration_date: The stock appreciation rights, which are subject to certain vesting requirements will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant. Read SEC document |
| February 25, 2010 Filed Mar 2, 2010 02:02 UTC |
RICCIARDI NATALE SSenior Vice President
|
Tax withholdingCommon Stock | 1,848 | $17.69 | $32,691.12 |
DisclosureSEC source: 0001225208-10-006402 · doc4.xml · nonDerivative · entry 3 RICCIARDI NATALE S · CIK 0001107158 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 378,851 F3 · shares: The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the earn-out of Performance-Contingent Shares. Read SEC document |
| February 25, 2010 Filed Mar 2, 2010 02:02 UTC |
RICCIARDI NATALE SSenior Vice President
|
GrantCommon Stock | 5,209 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-10-006402 · doc4.xml · nonDerivative · entry 2 RICCIARDI NATALE S · CIK 0001107158 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 380,699 F2 · shares: The reported transaction constitutes the earn-out of Performance-Contingent Shares. Read SEC document |
| February 25, 2010 Filed Mar 2, 2010 02:02 UTC |
RICCIARDI NATALE SSenior Vice President
|
GrantCommon Stock | 28,970 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-10-006402 · doc4.xml · nonDerivative · entry 1 RICCIARDI NATALE S · CIK 0001107158 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 375,490 F1 · shares: The reported transaction constitutes the grant of restricted stock units, which are subject to certain vesting requirements. Read SEC document |
| February 25, 2010 Filed Mar 2, 2010 02:02 UTC |
SCHULMAN AMY WSenior Vice President
|
GrantStock Appreciation Rights · Derivative | 84,459 | $0.00 Strike: $17.69 | $0.00 |
DisclosureSEC source: 0001225208-10-006403 · doc4.xml · derivative · entry 4 SCHULMAN AMY W · CIK 0001438226 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,459 Underlying: Common Stock · 84,459 shares Expires 2015-02-25 F3 · derivative.exercise_date: The stock appreciation rights, which are subject to certain vesting requirements will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant. F3 · derivative.expiration_date: The stock appreciation rights, which are subject to certain vesting requirements will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant. Read SEC document |
| February 25, 2010 Filed Mar 2, 2010 02:02 UTC |
SCHULMAN AMY WSenior Vice President
|
GrantCommon Stock | 36,211 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-10-006403 · doc4.xml · nonDerivative · entry 1 SCHULMAN AMY W · CIK 0001438226 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 182,653 F1 · shares: The reported transaction constitutes the grant of restricted stock units, which are subject to certain vesting requirements. Read SEC document |
| February 25, 2010 Filed Mar 2, 2010 02:02 UTC |
RINGO WILLIAM RSenior Vice President
|
GrantCommon Stock | 13,231 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-10-006404 · doc4.xml · nonDerivative · entry 1 RINGO WILLIAM R · CIK 0001238325 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 252,798 F1 · shares: The reported transaction constitutes the grant of restricted stock units, which are subject to certain vesting requirements. Read SEC document |
| February 22, 2010 Filed Feb 23, 2010 23:45 UTC |
CANGIALOSI LORETTA VSr. Vice President, Controller
|
Tax withholdingCommon Stock | 2,693 | $17.95 | $48,339.35 |
DisclosureSEC source: 0001225208-10-005402 · doc4.xml · nonDerivative · entry 1 CANGIALOSI LORETTA V · CIK 0001174449 · Sr. Vice President, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 178,860 F1 · kind: Represents withholding of shares to satisfy tax obligations upon vesting of restricted stock units. Read SEC document |
| February 22, 2010 Filed Feb 23, 2010 23:47 UTC |
RICCIARDI NATALE SSenior Vice President
|
Tax withholdingCommon Stock | 3,695 | $17.95 | $66,325.25 |
DisclosureSEC source: 0001225208-10-005403 · doc4.xml · nonDerivative · entry 1 RICCIARDI NATALE S · CIK 0001107158 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 346,520 F1 · kind: Represents withholding of shares to satisfy tax obligations upon vesting of restricted stock units. Read SEC document |
| February 09, 2010 Filed Jan 26, 2011 16:22 UTC |
KILTS JAMES MDirector
|
PurchaseCommon Stock | 549 | $18.12 | $9,947.88 |
DisclosureSEC source: 0001225208-11-003800 · doc4.xml · nonDerivative · entry 1 KILTS JAMES M · CIK 0001025094 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 549 Read SEC document |
| January 29, 2010 Filed Feb 2, 2010 16:54 UTC |
STEERE WILLIAM C JRDirector
|
Tax withholdingCommon Stock | 52,507 | $18.66 | $979,780.62 |
DisclosureSEC source: 0001225208-10-002970 · doc4.xml · nonDerivative · entry 1 STEERE WILLIAM C JR · CIK 0001033870 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,329,689 Read SEC document |
| December 31, 2009 Filed Jan 4, 2010 21:08 UTC |
RINGO WILLIAM RSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 137 | $18.19 Strike: $0.00 | $2,492.03 |
DisclosureSEC source: 0001225208-10-000237 · doc4.xml · derivative · entry 1 RINGO WILLIAM R · CIK 0001238325 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,028 Underlying: Common Stock · 137 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| December 31, 2009 Filed Jan 4, 2010 21:08 UTC |
SUSMAN SALLYSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 82 | $18.19 Strike: $0.00 | $1,491.58 |
DisclosureSEC source: 0001225208-10-000238 · doc4.xml · derivative · entry 1 SUSMAN SALLY · CIK 0001263544 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,474 Underlying: Common Stock · 82 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| December 31, 2009 Filed Jan 4, 2010 21:12 UTC |
CANGIALOSI LORETTA VSr. Vice President, Controller
|
GrantPhantom Stock Units SSP · Derivative | 61 | $18.19 Strike: $0.00 | $1,109.59 |
DisclosureSEC source: 0001225208-10-000243 · doc4.xml · derivative · entry 1 CANGIALOSI LORETTA V · CIK 0001174449 · Sr. Vice President, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,450 Underlying: Common Stock · 61 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| December 31, 2009 Filed Jan 4, 2010 21:12 UTC |
RICCIARDI NATALE SSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 76 | $18.19 Strike: $0.00 | $1,382.44 |
DisclosureSEC source: 0001225208-10-000244 · doc4.xml · derivative · entry 1 RICCIARDI NATALE S · CIK 0001107158 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,734 Underlying: Common Stock · 76 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| December 31, 2009 Filed Jan 4, 2010 21:12 UTC |
DAMELIO FRANK ASenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 109 | $18.19 Strike: $0.00 | $1,982.71 |
DisclosureSEC source: 0001225208-10-000245 · doc4.xml · derivative · entry 1 DAMELIO FRANK A · CIK 0001194004 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,668 Underlying: Common Stock · 109 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| December 31, 2009 Filed Jan 4, 2010 21:12 UTC |
MACKAY MARTINSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 104 | $18.19 Strike: $0.00 | $1,891.76 |
DisclosureSEC source: 0001225208-10-000246 · doc4.xml · derivative · entry 1 MACKAY MARTIN · CIK 0001414815 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,265 Underlying: Common Stock · 104 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| December 31, 2009 Filed Jan 4, 2010 21:12 UTC |
KINDLER JEFFREY BDirector · Chairman & CEO
|
GrantPhantom Stock Units SSP · Derivative | 163 | $18.19 Strike: $0.00 | $2,964.97 |
DisclosureSEC source: 0001225208-10-000249 · doc4.xml · derivative · entry 1 KINDLER JEFFREY B · CIK 0001174454 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,657 Underlying: Common Stock · 163 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| December 31, 2009 Filed Jan 4, 2010 21:12 UTC |
Lewis-Hall Freda CSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 92 | $18.19 Strike: $0.00 | $1,673.48 |
DisclosureSEC source: 0001225208-10-000250 · doc4.xml · derivative · entry 1 Lewis-Hall Freda C · CIK 0001437909 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 741 Underlying: Common Stock · 92 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| December 31, 2009 Filed Jan 4, 2010 21:12 UTC |
READ IAN CSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 284 | $18.19 Strike: $0.00 | $5,165.96 |
DisclosureSEC source: 0001225208-10-000251 · doc4.xml · derivative · entry 1 READ IAN C · CIK 0001372915 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,668 Underlying: Common Stock · 284 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| December 31, 2009 Filed Jan 5, 2010 20:25 UTC |
KILTS JAMES MDirector
|
GrantPhantom Stock Units · Derivative | 1,714 | $18.19 Strike: $0.00 | $31,177.66 |
DisclosureSEC source: 0001225208-10-000578 · doc4.xml · derivative · entry 1 KILTS JAMES M · CIK 0001025094 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,460 Underlying: Common Stock · 1,714 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors. F2 · derivative.expiration_date: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors. Read SEC document |
| December 31, 2009 Filed Jan 5, 2010 20:25 UTC |
MEAD DANA GDirector
|
GrantPhantom Stock Units · Derivative | 2,200 | $18.19 Strike: $0.00 | $40,018.00 |
DisclosureSEC source: 0001225208-10-000579 · doc4.xml · derivative · entry 1 MEAD DANA G · CIK 0001174482 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,117 Underlying: Common Stock · 2,200 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors. F2 · derivative.expiration_date: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors. Read SEC document |
| December 31, 2009 Filed Jan 5, 2010 20:25 UTC |
SANGER STEPHEN WDirector
|
GrantPhantom Stock Units · Derivative | 1,729 | $18.19 Strike: $0.00 | $31,450.51 |
DisclosureSEC source: 0001225208-10-000580 · doc4.xml · derivative · entry 1 SANGER STEPHEN W · CIK 0001204994 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,473 Underlying: Common Stock · 1,729 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors. F2 · derivative.expiration_date: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors. Read SEC document |
| December 31, 2009 Filed Jan 5, 2010 20:25 UTC |
STEERE WILLIAM C JRDirector
|
GrantPhantom Stock Units · Derivative | 1,484 | $18.19 Strike: $0.00 | $26,993.96 |
DisclosureSEC source: 0001225208-10-000581 · doc4.xml · derivative · entry 1 STEERE WILLIAM C JR · CIK 0001033870 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,055 Underlying: Common Stock · 1,484 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors. F2 · derivative.expiration_date: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors. Read SEC document |
| December 31, 2009 Filed Feb 1, 2010 19:30 UTC |
CANGIALOSI LORETTA VSr. Vice President, Controller
|
GrantStock Appreciation Rights · Derivative | 32,120 | $0.00 Strike: $18.19 | $0.00 |
DisclosureSEC source: 0001225208-10-002748 · doc4.xml · derivative · entry 3 CANGIALOSI LORETTA V · CIK 0001174449 · Sr. Vice President, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,120 Underlying: Common Stock · 32,120 shares Expires 2014-12-31 F2 · derivative.exercise_date: The stock appreciation rights will vest on the third anniversary of the date of grant, provided that the reporting person remains in the continuous employ of Pfizer until that anniversary date, and will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant. F2 · derivative.expiration_date: The stock appreciation rights will vest on the third anniversary of the date of grant, provided that the reporting person remains in the continuous employ of Pfizer until that anniversary date, and will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.